Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 2, 2026

Bitfarms Announces Complete Exit from Latam with Sale of its Paso Pe Site for up to $30M

View original at globenewswire.com
Bitfarms Announces Complete Exit from Latam with Sale of its Paso Pe Site for up to $30M -Rebalances energy assets portfolio to 100% North American- -Bitfarms to reinvest capital in North American HPC/AI energy infrastructure- TORONTO, Ontario and NEW YORK, Jan…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Bitfarms will be able to generate much stronger returns on invested capital with HPC/AI compared to previous operations

    80% confidence
  • Transaction is expected to close within 60 days

    80% confidence
  • The transaction brings forward an estimated two to three years of anticipated free cash flows from operations to be reinvested into North American HPC/AI energy infrastructure in 2026

    80% confidence
  • This transaction accelerates SPF's regional expansion plan with priority on uninterrupted, seamless transition at Paso Pe

    80% confidence
  • The sale of Paso Pe is the culmination of a series of transactions to completely exit Latam and refocus the company on 100% North American power and infrastructure for HPC/AI

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com